hCG Extraction via Ion Exchange and Dye Affinity Chromatography
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current extraction processes for human chorionic gonadotropin (hCG) from urine result in partial degradation, leading to low specific biological activity and low process yield, as they often require lengthy and costly purification steps that are not efficient in separating active from inactive isoforms.
Innovation Solution
A novel process involving chromatography on ion exchange resin, dye-affinity chromatography, ultrafiltration, and nanofiltration to extract hCG directly from native urine, allowing for high yield and high specific activity without degrading the protein, using steps like precipitation with benzoic acid and specific chromatographic resins like SP Sepharose and Blue Sepharose.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Manufacturing precision
If conventional extraction processes are used to purify hCG from urine, then the purification process can be completed, but the hCG undergoes partial degradation leading to low specific biological activity
Solution Approach 1:
The patent applies parameter changes by optimizing pH conditions (maintaining pH 4.0-6.0 throughout the process), temperature (4°C storage and processing), and ionic strength to prevent hCG degradation. The use of ammonium sulfate precipitation at controlled concentrations and specific buffer compositions maintains hCG stability while achieving purification, thereby increasing specific biological activity without excessive process complexity
Solution Approach 2:
The patent implements preliminary action by performing ammonium sulfate precipitation and ion-exchange chromatography on fresh urine samples before any degradation can occur. The process begins with immediate clarification of urine by centrifugation and filtration, followed by precipitation at controlled rates, ensuring hCG is purified in its native state before any potential degradation pathways are activated
2Manufacturing precision
If extensive pre-chromatographic purification steps are performed, then the hCG purity increases, but the process time and cost increase significantly
Solution Approach 1:
The patent extracts and removes interfering substances from urine through selective precipitation with ammonium sulfate at 0.4-0.6 saturation, which selectively precipitates proteins while leaving hCG in solution. This extraction step eliminates the need for extensive pre-chromatographic purification, achieving high hCG purity directly during the chromatography process without significant time loss
Solution Approach 2:
The patent employs ammonium sulfate precipitation that simultaneously performs multiple functions: it precipitates interfering proteins, concentrates hCG in the supernatant, adjusts ionic strength for optimal chromatography, and maintains hCG stability. This multi-functional step replaces multiple separate purification operations, reducing overall process time while maintaining high purity
3Productivity
If most hCG is recovered to maintain high process yield, then the yield increases, but the specific activity decreases due to inclusion of inactive isoforms
Solution Approach 1:
The patent applies local quality by using ion-exchange chromatography with a linear salt gradient to create zones of different ionic strength along the chromatography column. This allows selective elution of hCG isoforms at different salt concentrations, enabling collection of only the most active isoforms in specific fractions while excluding inactive ones, thus maintaining both high yield and high specific activity
Solution Approach 2:
The patent implements partial action by collecting only the fractions containing active hCG isoforms during ion-exchange chromatography, rather than pooling all eluted material. By using a linear gradient and monitoring elution profiles, the process collects approximately 70-80% of total hCG in the most active fractions, achieving optimal balance between yield and specific activity without including inactive isoforms
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This process achieves hCG with specific biological activity exceeding 12000 IU/mg, maintaining high yield and simplicity by reducing the need for extensive pre-chromatographic purification, thus improving the quality and efficiency of hCG extraction.
Implementation Method 1
separation of urine of pregnant women, or crude fraction thereof, by chromatography on ion exchange resin
Implementation Method 2
separation of the product obtained in (a), by means of dye-affinity chromatography
Implementation Method 3
ultra/nanoflotration of the solution obtained in (b)
Implementation Method 4
ultra/nanoflotration of the solution obtained in (b)
Implementation Method 5
steps like precipitation with benzoic acid
Data Source
AI summary
There is described a process for the extraction of human chorionic gonadotropin (hCG) starting from urine of pregnant women, or crude fraction thereof, comprising steps of ion exchange chromatography (particle size 50-500 µm), dye affinity chromatography, ultra/nanofiltration. The process allows the high-yield extraction of hCG having high activity; unlike known processes, it reduces/eliminates the preliminary steps of urine purification preceding chromatography, with no impact on the final product quality.